Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence

Journal of the American Society of Hypertension

Volumn 7, Issue 6, 2013, Pages 471-476

  Grigoryan, Larissa ^a   Pavlik, Valory N ^a   Hyman, David J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

drug dosage; electronic monitoring; medication adherence; Resistant hypertension; white coat hypertension

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; WHITE COAT HYPERTENSION;

DRUG DOSAGE; ELECTRONIC MONITORING; MEDICATION ADHERENCE; RESISTANT HYPERTENSION; WHITE-COAT HYPERTENSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRIMARY HEALTH CARE; WHITE COAT HYPERTENSION;

EID: 84890430760     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2013.06.004     Document Type: Article

References (29)

1. D.A. Calhoun, D. Jones, S. Textor, D.C. Goff, T.P. Murphy, and R.D. Toto Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation 117 2008 e510 e526
2. C. Cuspidi, G. Macca, L. Sampieri, I. Michev, M. Salerno, and V. Fusi High prevalence of cardiac and extracardiac target organ damage in refractory hypertension Journal Hypertens 19 2001 2063 2070
3. S.D. Persell Prevalence of resistant hypertension in the United States, 2003-2008 Hypertension 57 2011 1076 1080
4. A. de la Sierra, J. Segura, J.R. Banegas, M. Gorostidi, J.J. de la Cruz, and P. Armario Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring Hypertension 57 2011 898 902
5. M.C. Acelajado, R. Pisoni, T. Dudenbostel, L.J. Dell'Italia, F. Cartmill, and B. Zhang Refractory hypertension: definition, prevalence, and patient characteristics J Clin Hypertens (Greenwich) 14 2012 7 12
6. M.R. Irvin, D. Shimbo, D.M. Mann, K. Reynolds, M. Krousel-Wood, and N.A. Limdi Prevalence and correlates of low medication adherence in apparent treatment-resistant hypertension J Clin Hypertens (Greenwich) 14 2012 694 700
7. B.M. Egan, Y. Zhao, R.N. Axon, W.A. Brzezinski, and K.C. Ferdinand Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008 Circulation 124 2011 1046 1058
8. S.L. Daugherty, J.D. Powers, D.J. Magid, H.M. Tavel, F.A. Masoudi, and K.L. Margolis Incidence and prognosis of resistant hypertension in hypertensive patients Circulation 125 2012 1635 1642
9. A. de la Sierra, J.R. Banegas, A. Oliveras, M. Gorostidi, J. Segura, and J. de la Cruz Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs J Hypertens 30 2012 1211 1216
10. J. Barochiner, J. Alfie, L.S. Aparicio, P.E. Cuffaro, M.A. Rada, and M.S. Morales Prevalence and clinical profile of resistant hypertension among treated hypertensive subjects Clin Exp Hypertens 2012 (in press)
11. M.R. Hanselin, J.J. Saseen, R.R. Allen, J.C. Marrs, and K.V. Nair Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents Hypertension 58 2011 1008 1013
12. E. Yiannakopoulou, J.S. Papadopulos, D.V. Cokkinos, and T.D. Mountokalakis Adherence to antihypertensive treatment: a critical factor for blood pressure control Eur J Cardiovasc Prev Rehabil 12 2005 243 249
13. L. Grigoryan, V.N. Pavlik, and D.J. Hyman Predictors of antihypertensive medication adherence in two urban health-care systems Am J Hypertens 25 2012 735 738
14. G. Ogedegbe, W. Chaplin, A. Schoenthaler, D. Statman, D. Berger, and T. Richardson A practice-based trial of motivational interviewing and adherence in hypertensive African Americans Am J Hypertens 21 2008 1137 1143
15. V.N. Pavlik, A.J. Greisinger, J. Pool, P. Haidet, and D.J. Hyman Does reducing physician uncertainty improve hypertension control? rationale and methods Circ Cardiovasc Qual Outcomes 2 2009 257 263
16. D.J. Hyman, V.N. Pavlik, A.J. Greisinger, W. Chan, J. Bayona, and C. Mansyur Effect of a physician uncertainty reduction intervention on blood pressure in uncontrolled hypertensives-a cluster randomized trial J Gen Intern Med 27 2012 413 419
17. D.A. Sica Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy? Drugs 48 1994 16 24
18. G.J. Okano, K.L. Rascati, J.P. Wilson, D.D. Remund, J.D. Grabenstein, and D.I. Brixner Patterns of antihypertensive use among patients in the us department of defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker Clin Ther 19 1997 1433 1445 discussion 1424-35
19. P.W. Choo, C.S. Rand, T.S. Inui, M.L. Lee, E. Cain, and M. Cordeiro-Breault Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy Med Care 37 1999 846 857
20. P. Verdecchia, G. Reboldi, C. Porcellati, G. Schillaci, S. Pede, and M. Bentivoglio Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects J Am Coll Cardiol 39 2002 878 885
21. C.S. Wiysonge, H.A. Bradley, J. Volmink, B.M. Mayosi, A. Mbewu, and L.H. Opie Beta-blockers for hypertension Cochrane Database Syst Rev 8 2012 CD002003
22. A.R. De Caterina, and A.M. Leone The role of beta-blockers as first-line therapy in hypertension Curr Atheroscler Rep 13 2011 147 153
23. F.H. Messerli, H. Makani, A. Benjo, J. Romero, C. Alviar, and S. Bangalore Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials J Am Coll Cardiol 57 2011 590 600
24. M.A. Brown, M.L. Buddle, and A. Martin Is resistant hypertension really resistant? Am J Hypertens 14 2001 1263 1269
25. J. Bunker, W. Callister, C.L. Chang, and P.S. Sever How common is true resistant hypertension? J Hum Hypertens 25 2011 137 140
26. R.E. Schmieder, M.V. Lehmann, and S. Schmidt Optimizing blood pressure control in hypertension: The need to use abpm Blood Press 22 2013 65 72
27. A.J. Rose, D.R. Berlowitz, M. Manze, M.B. Orner, and N.R. Kressin Intensifying therapy for hypertension despite suboptimal adherence Hypertension 54 2009 524 529
28. A.J. Rose, M.E. Glickman, M.M. D'Amore, M.B. Orner, D. Berlowitz, and N.R. Kressin Effects of daily adherence to antihypertensive medication on blood pressure control J Clin Hypertens (Greenwich) 13 2011 416 421
29. L. Grigoryan, V.N. Pavlik, and D.J. Hyman Patterns of nonadherence to antihypertensive therapy in primary care J Clin Hypertens (Greenwich) 15 2013 107 111